AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36

Authors: Storb, R Blume, KG O'Donnell, MR Chauncey, T Forman, SJ Deeg, HJ Hu, WW Appelbaum, FR Doney, K Flowers, MED Sanders, J Leisenring, W
Citation: R. Storb et al., Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters, BIOL BLOOD, 7(1), 2001, pp. 39-44

Authors: Forman, SJ
Citation: Sj. Forman, Marrow vs peripheral blood: impact on transplant outcome, LEUKEMIA, 15(4), 2001, pp. 686-687

Authors: Horak, DA Forman, SJ
Citation: Da. Horak et Sj. Forman, Critical care of the hematopoietic stem cell patient, CRIT CARE C, 17(3), 2001, pp. 671

Authors: Bhatia, S Louie, AD Bhatia, R O'Donnell, MR Fung, H Kashyap, A Krishnan, A Molina, A Nademanee, A Niland, JC Parker, PA Snyder, DS Spielberger, R Stein, A Forman, SJ
Citation: S. Bhatia et al., Solid cancers after bone marrow transplantation, J CL ONCOL, 19(2), 2001, pp. 464-471

Authors: Fung, HC Nademanee, AP Bhatia, S Forman, SJ
Citation: Hc. Fung et al., Is there an association between total-body irradiation and secondary acutemyelogenous leukemia/myelodysplastic syndrome in patients with relapsed/refractory Hodgkin's disease treated with autologous stem-cell transplantation?, J CL ONCOL, 19(15), 2001, pp. 3585-3587

Authors: Khoury, H Kashyap, A Adkins, DR Brown, RA Miller, G Vij, R Westervelt, P Trinkaus, K Goodnough, LT Hayashi, RJ Parker, P Forman, SJ DiPersio, J
Citation: H. Khoury et al., Graft-versus-host disease - Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin, BONE MAR TR, 27(10), 2001, pp. 1059-1064

Authors: Bensinger, WI Martin, PJ Storer, B Clift, R Forman, SJ Negrin, R Kashyap, A Flowers, MED Lilleby, K Chauncey, TR Storb, R Rowley, S Heimfeld, S Blume, K
Citation: Wi. Bensinger et al., Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers., N ENG J MED, 344(3), 2001, pp. 175-181

Authors: Somlo, G Doroshow, JH Synold, T Longmate, J Reardon, D Chow, W Forman, SJ Leong, LA Margolin, KA Morgan, RJ Raschko, JW Shibata, SI Tetef, ML Yen, Y Kogut, N Schriber, J Alvarnas, J
Citation: G. Somlo et al., High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome, BR J CANC, 84(12), 2001, pp. 1591-1598

Authors: Shih, CC Weng, YH Mamelak, A LeBon, T Hu, MCT Forman, SJ
Citation: Cc. Shih et al., Identification of a candidate human neurohematopoietic stem-cell population, BLOOD, 98(8), 2001, pp. 2412-2422

Authors: Krishnan, A Molina, A Zaia, J Nademanee, A Kogut, N Rosenthal, J Woo, D Forman, SJ
Citation: A. Krishnan et al., Autologous stem cell transplantation for HIV-associated lymphoma, BLOOD, 98(13), 2001, pp. 3857-3859

Authors: Snyder, DS Nademanee, AP O'Donnell, MR Parker, PM Stein, AS Margolin, K Somlo, G Molina, A Spielberger, R Kashyap, A Fung, H Vora, N Slovak, ML Niland, J Palmer, J Negrin, RS Amylon, MD Blume, KG Forman, SJ
Citation: Ds. Snyder et al., Allogeneic bone marrow transplantation for BCR-ABL positive acute lymphoblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 414-418

Authors: Shih, CC DiGiusto, D Forman, SJ
Citation: Cc. Shih et al., Ex vivo expansion of transplantable human hematopoietic stem cells: Where do we stand in the year 2000?, J HEMATH ST, 9(5), 2000, pp. 621-628

Authors: Jensen, MC Clarke, P Tan, G Wright, C Wen, CC Clark, TN Zhang, FY Slovak, ML Wu, AM Forman, SJ Raubitschek, A
Citation: Mc. Jensen et al., Human T lymphocyte genetic modification with naked DNA, MOL THER, 1(1), 2000, pp. 49-55

Authors: Kashyap, A Kandeel, F Yamauchi, D Palmer, JM Niland, JC Molina, A Fung, H Bhatia, R Krishnan, A Nademanee, A O'Donnell, MR Parker, P Rodriguez, R Snyder, D Spielberger, R Stein, A Nadler, J Forman, SJ
Citation: A. Kashyap et al., Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study, BIOL BLOOD, 6(3A), 2000, pp. 344-351

Authors: Chao, NJ Snyder, DS Jain, M Wong, RM Niland, JC Negrin, RS Long, GD Hu, WW Stockerl-Goldstein, KE Johnston, LJ Amylon, MD Tierney, DK O'Donnell, MR Nademanee, AP Parker, P Stein, A Molina, A Fung, H Kashyap, A Kohler, S Spielberger, R Krishnan, A Rodriguez, R Forman, SJ Blume, KG
Citation: Nj. Chao et al., Equivalence of 2 effective graft-versus-host disease prophylaxis regimens:Results of a prospective double-blind randomized trial, BIOL BLOOD, 6(3), 2000, pp. 254-261

Authors: Margolin, K Forman, SJ
Citation: K. Margolin et Sj. Forman, Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy, CA J SCI AM, 6, 2000, pp. S33-S38

Authors: Zhang, FF Murata-Collins, JL Gaytan, P Forman, SJ Kopecky, KJ Willman, CL Appelbaum, FR Slovak, ML
Citation: Ff. Zhang et al., Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia, GENE CHROM, 28(3), 2000, pp. 318-328

Authors: Stein, AS O'Donnell, MR Slovak, ML Nademanee, A Dagis, A Schmidt, GM Parker, PM Snyder, DS Smith, EP Somlo, G Margolin, KA Arber, D Niland, J Forman, SJ
Citation: As. Stein et al., High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission, LEUKEMIA, 14(7), 2000, pp. 1191-1196

Authors: Shih, CC Hu, J Arber, D LeBon, T Forman, SJ
Citation: Cc. Shih et al., Transplantation and growth characteristics of human fetal lymph node in immunodeficient mice, EXP HEMATOL, 28(9), 2000, pp. 1046-1053

Authors: Bhatia, R Munthe, HA Williams, AD Zhang, F Forman, SJ Slovak, ML
Citation: R. Bhatia et al., Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation, EXP HEMATOL, 28(12), 2000, pp. 1401-1412

Authors: Andersson, BS Gajewski, J Donato, M Giralt, S Gian, V Wingard, J Tarantolo, S Fernandez, H Hu, WW Blume, K Kashyap, A Forman, SJ Champlin, RE
Citation: Bs. Andersson et al., Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy), BONE MAR TR, 25, 2000, pp. S35-S38

Authors: Louie, AD Robison, LL Bogue, M Hyde, S Forman, SJ Bhatia, S
Citation: Ad. Louie et al., Validation of self-reported complications by bone marrow transplantation survivors, BONE MAR TR, 25(11), 2000, pp. 1191-1196

Authors: Ahuja, HG Hong, JM Aplan, PD Tcheurekdjian, L Forman, SJ Slovak, ML
Citation: Hg. Ahuja et al., t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF), CANCER RES, 60(22), 2000, pp. 6227-6229

Authors: Molina, A Krishnan, AY Nademanee, A Zabner, R Sniecinski, I Zaia, J Forman, SJ
Citation: A. Molina et al., High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy, CANCER, 89(3), 2000, pp. 680-689

Authors: Shih, CC Forman, SJ
Citation: Cc. Shih et Sj. Forman, Response - Leukemia inhibitory factor does not have a direct effect on theexpansion of transplantable human hematopoietic stern cells, BLOOD, 96(3), 2000, pp. 1200-1201
Risultati: 1-25 | 26-36